How Puma Biotechnology, Inc. stacks up

PBYI · against 461 other Healthcare companies of similar size

Overall

58/ 100

Above the middle of the pack.

Ranked #136 of 462 · scores higher than 70% of peers

Bars: peers in each 10-point band of the overall score

84 peers with an overall score of 50–59, including PBYI · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#119 of 466Score 76 / 100 · beats 74%Growth#305 of 422Score 18 / 100 · beats 26%Profitability#31 of 464Score 90 / 100 · beats 93%Risk#268 of 474Moderate relative risk · safety 49 · beats 44%

Ranking by overall score

Top 5 and the companies ranked around PBYI

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Arbutus Biopharma CorporationABUS · US-listed	595M USD	97	96	98	99	0 / 2
2	Zevra Therapeutics, Inc.ZVRA · US-listed	609M USD	91	95	99	99	0 / 2
3	Beijing Chunlizhengda Medical Instruments Co., Ltd.1858.HK · Hong Kong	2.9B HKD (≈$365M)	84	99	63	86	0 / 2
4	Amoy Diagnostics Co., Ltd.300685.SZ · China	7.5B CNY (≈$1.1B)	82	72	64	96	0 / 2
5	CorMedix Inc.CRMD · US-listed	433M USD	81	96	99	99	2 / 2
⋯
136	Vital KSK Holdings, Inc.3151.T · Japan	72.6B JPY (≈$494M)	58	96	36	40	1 / 2
136	Arvinas, Inc.ARVN · US-listed	457M USD	58	52	78	36	1 / 2
136	Bangkok Chain Hospital Public Company LimitedBCH.BK · Southeast Asia	26.7B THB (≈$747M)	58	75	21	73	1 / 2
136	Dishman Carbogen Amcis LimitedDCAL.NS · India	23.7B INR (≈$284M)	58	68	88	40	1 / 2
136	Puma Biotechnology, Inc.PBYI · US-listed	528M USD	58	76	18	90	1 / 2
142	KYORIN Pharmaceutical Co., Ltd.4569.T · Japan	63.5B JPY (≈$432M)	57	76	31	41	0 / 2
142	BioAge Labs, Inc.BIOA · US-listed	274M USD	57	33	95	5	0 / 2
142	Community Health Systems, Inc.CYH · US-listed	289M USD	57	96	67	64	2 / 2
142	PT Medikaloka Hermina TbkHEAL.JK · Southeast Asia	7.13T IDR (≈$442M)	57	91	47	66	2 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…